» Articles » PMID: 28589097

AGO2 Negatively Regulates Type I Interferon Signaling Pathway by Competition Binding IRF3 with CBP/p300

Overview
Date 2017 Jun 8
PMID 28589097
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Viral infection triggers a series of signaling cascades and host innate immune responses, including interferon (IFN) production, which depends on coordinated activity of multiple transcription factors. IFN regulatory factor 3 (IRF3) and transcriptional coactivator CREB binding protein (CBP) and/or p300 are core factors that participate in transcriptional complex formation in the nucleus. In general, cells balance the production of IFNs through suppressive and stimulative mechanisms, but viral infections can disrupt such equilibrium. This study determined that H5N1 viral infection reduced the distribution of human argonaute 2 (AGO2) in A549 cell nucleus. AGO2 did not block phosphorylation, nuclear translocation, and DNA binding ability of IRF3 but inhibited its association with CBP. Therefore, this newly revealed mechanism shows that cellular response leads to transfer of AGO2 from cell nucleus and promotes IFN-β expression to increase host survival during viral infection.

Citing Articles

Zinc-finger CCHC-type containing protein 8 promotes RNA virus replication by suppressing the type-I interferon responses.

Tu S, Zou J, Xiong C, Dai C, Sun H, Luo D J Virol. 2024; 98(9):e0079624.

PMID: 39115433 PMC: 11406956. DOI: 10.1128/jvi.00796-24.


Loss of Lamin A leads to the nuclear translocation of AGO2 and compromised RNA interference.

Lobo V, Nowak I, Fernandez C, Correa Muler A, Westholm J, Huang H Nucleic Acids Res. 2024; 52(16):9917-9935.

PMID: 38994560 PMC: 11381323. DOI: 10.1093/nar/gkae589.


Foot-and-mouth disease virus VP1 degrades YTHDF2 through autophagy to regulate IRF3 activity for viral replication.

Liu H, Xue Q, Yang F, Cao W, Liu P, Liu X Autophagy. 2024; 20(7):1597-1615.

PMID: 38516932 PMC: 11210904. DOI: 10.1080/15548627.2024.2330105.


Virus-Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid Assays.

Corneillie L, Lemmens I, Weening K, De Meyer A, Van Houtte F, Tavernier J Viruses. 2023; 15(12).

PMID: 38140653 PMC: 10748205. DOI: 10.3390/v15122412.


NOG1 downregulates type I interferon production by targeting phosphorylated interferon regulatory factor 3.

Xue Q, Zhu Z, Xue Z, Yang F, Cao W, Liu X PLoS Pathog. 2023; 19(7):e1011511.

PMID: 37410776 PMC: 10353805. DOI: 10.1371/journal.ppat.1011511.


References
1.
Cho S, Park J, Kang Y . AGO2 and SETDB1 cooperate in promoter-targeted transcriptional silencing of the androgen receptor gene. Nucleic Acids Res. 2014; 42(22):13545-56. PMC: 4267665. DOI: 10.1093/nar/gku788. View

2.
Ye Z, Jin H, Qian Q . Argonaute 2: A Novel Rising Star in Cancer Research. J Cancer. 2015; 6(9):877-82. PMC: 4532985. DOI: 10.7150/jca.11735. View

3.
Lin C, Hare B, Wagner G, Harrison S, Maniatis T, FRAENKEL E . A small domain of CBP/p300 binds diverse proteins: solution structure and functional studies. Mol Cell. 2001; 8(3):581-90. DOI: 10.1016/s1097-2765(01)00333-1. View

4.
Kok K, Lui P, Ng M, Siu K, Au S, Jin D . The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe. 2011; 9(4):299-309. DOI: 10.1016/j.chom.2011.03.007. View

5.
Ivashkiv L, Donlin L . Regulation of type I interferon responses. Nat Rev Immunol. 2013; 14(1):36-49. PMC: 4084561. DOI: 10.1038/nri3581. View